Clene (CLNN) Gets a Buy from JonesTrading
JonesTrading's Justin Walsh reiterated a Buy rating on Clene (CLNN) with a $30 price target. Walsh, a 4-star analyst, has a 12.8% average return and a 33.22% success rate. Clene also received a Buy from Maxim Group's Naz Rahman, while TR | OpenAI – 4o maintained a Hold rating on November 26.
In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Clene, with a price target of $30.00.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
According to TipRanks, Walsh is a 4-star analyst with an average return of 12.8% and a 33.22% success rate. Walsh covers the Healthcare sector, focusing on stocks such as Alto Neuroscience, Inc., Perspective Therapeutics, and Achieve Life Sciences.
In addition to JonesTrading, Clene also received a Buy from Maxim Group’s Naz Rahman in a report issued today. However, on November 26, TR | OpenAI – 4o reiterated a Hold rating on Clene (NASDAQ: CLNN).
